Cristiana Spontoni

Popular Topics

Food, Drugs, Healthcare, Life Sciences Strategy Technology Consumer Protection Government, Public Sector

Cristiana Spontoni’s articles from Jones Day are most popular:

in Asia and South America

DETAILS

Belgium

www.jonesday.com

+32 00 26451411

RANKINGS

author rankings top 20% image

This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in Belgium

AUTHORS CONTENT

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 128

European Union International

Vital Signs: Digital Health Law Update | Spring/Summer 2026

United States Healthcare

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 127

European Union Government

The Revised EU Product Liability Directive: State Of Play Across EU Member States And Evolving Risk Landscape

Belgium Consumer

Innovative Insights: Legal Updates In The Life Sciences

United States Healthcare

UK Clinical Trials Enter A New Regulatory Era

United Kingdom Healthcare

A Major Overhaul Of The UK Product Safety And Market Surveillance And Enforcement Regime

United Kingdom Consumer

The Proposed European Biotech Act, 100 Days On

Afghanistan Healthcare

A Tough Dose: 100% Tariffs Target Foreign-Manufactured Brand-Name Pharmaceuticals

United States Healthcare

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 126

European Union Technology

The UK's MHRA Opens Public Consultation On Indefinite CE Mark Recognition Of Medical Devices And IVDs

United Kingdom Healthcare

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 125

United States Strategy

Vital Signs: Digital Health Law Update | Winter 2026

United States Healthcare

EMA And FDA Align On Good AI Practice In Drug Development

United States Technology

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 124

European Union Government

The EU Pharma Package Is A Done Deal: A Holiday Gift, Or Not?

Global Healthcare

FDA's Biosimilar Playbook: Merging Biosimilarity With Interchangeability

United States Healthcare

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 123

European Union Strategy

FDA Proposes To Remove Comparative Efficacy Studies To Accelerate Biosimilar Development

United States Healthcare

Italy Leads The Way In Shaping National AI Legislation Within The EU

European Union Technology

AWARDS

Autumn 2022 Award for Food, Drugs, Healthcare, Life Sciences in United Kingdom

Food, Drugs, Healthcare, Life Sciences

COVID-19 Key EU Developments, Policy & Regulatory Update No. 82

Autumn 2022 Award for Energy and Natural Resources in United Kingdom

Energy and Natural Resources

COVID-19 Key EU Developments, Policy & Regulatory Update No. 82

Spring 2022 Award for Antitrust/Competition Law in United Kingdom

Antitrust/Competition Law

COVID-19 Key EU Developments, Policy & Regulatory Update No. 63

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More